The store will not work correctly when cookies are disabled.
(3-chlorophenyl)(2-hydroxy-4,6-dimethoxy-3-(morpholinomethyl)phenyl)methanone
ID: ALA1093731
PubChem CID: 46884328
Max Phase: Preclinical
Molecular Formula: C20H22ClNO5
Molecular Weight: 391.85
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2cccc(Cl)c2)c(O)c1CN1CCOCC1
Standard InChI: InChI=1S/C20H22ClNO5/c1-25-16-11-17(26-2)18(19(23)13-4-3-5-14(21)10-13)20(24)15(16)12-22-6-8-27-9-7-22/h3-5,10-11,24H,6-9,12H2,1-2H3
Standard InChI Key: KLFRQQKLDHGYOA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.3069 -9.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3057 -10.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0206 -10.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7370 -10.4852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7341 -9.6547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0188 -9.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5909 -10.8976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8768 -10.4845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0163 -8.4205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7295 -8.0059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4521 -10.8966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4471 -9.2395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1631 -9.6493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4439 -8.4145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1628 -10.4719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8780 -10.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5919 -10.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5861 -9.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8704 -9.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0204 -11.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3058 -12.1359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5926 -11.7248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8801 -12.1336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8757 -12.9590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5899 -13.3738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3085 -12.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2976 -9.2194 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
3 20 1 0
9 10 1 0
20 21 1 0
21 22 1 0
2 3 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
12 13 1 0
18 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 391.85 | Molecular Weight (Monoisotopic): 391.1187 | AlogP: 3.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 68.23 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.46 | CX Basic pKa: 5.25 | CX LogP: 3.53 | CX LogD: 2.76 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.76 | Np Likeness Score: -0.51 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |